AccessibilityHelpAbout Us
Novozymes A/s logo

Novozymes A/s(OTC) NVZMF

Market Cap$30.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+137%
5 Year-4%
1 Year+10%
1 Month-8%
$65.00
-3.87%
-2.62Today
Novozymes A/s last closing stock price
MetricPriceDate
Last closeUSD 65.002026-09-25
Novozymes A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2%USD 66.332026-09-18
1 month-8.35%USD 70.932026-08-26
3 month+8.91%USD 59.682026-06-25
Year to date+5.88%USD 61.392025-12-30
1 year+10.46%USD 58.842025-09-25
3 year+69.41%USD 38.372023-09-26
5 year-4.46%USD 68.032021-09-24
Since inception+136.57%USD 27.482003-06-27

Novozymes A/s Financials at a Glance

Market Cap

$30.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€4.29B

Net Income (TTM)

€630.74M

EPS (TTM)

$1.58

P/E Ratio

41.12

Dividend

$1.02

Beta (Volatility)

0.18 (Low)

Price

$65.00

Volume

584

Open

$65.00

Previous Close

$65.00

Daily Range

$65.00 - $65.00

52-Week Range

$52.10 - $72.98

Estimated Earnings Date

Nov 5, 2026

NVZMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novozymes A/s

Novozymes A/S is a leading provider of biological solutions, specializing in industrial enzymes, microorganisms, and probiotics. Established in 1925 and headquartered in Bagsvaerd, Denmark, the company serves diverse sectors globally, including food and beverage, household care, agriculture, and industrial processing.

Products and Services
  • Industrial enzymes for food and beverage applications
  • Microorganisms and probiotics for agriculture and animal health
  • Biological solutions for household cleaning and industrial processing
Growth Outlook
  • Revenue growth driven by increasing demand for sustainable solutions
  • Expansion into emerging markets enhances global reach
  • Investment in R&D supports innovation and product development
Financial Highlights
  • Q2 2026 revenue of 1.11 billion EUR, reflecting strong market demand
  • Net income of 171 million EUR in Q2 2026, showcasing profitability
  • TTM gross profit margin of 54.9%, indicating operational efficiency
Novozymes A/S stands out in the specialty chemicals industry with its commitment to sustainability and innovation. The company's diverse product offerings cater to various sectors, positioning it well for future growth. Recent financial performance highlights a robust revenue stream and profitability, underscoring the effectiveness of its business model. The focus on research and development further enhances its competitive edge, making it an attractive option for investors interested in sustainable and innovative solutions.
AI Generated • Sep 15, 2026

Industry

Chemicals

Sector

Materials

Employees

11,641

CEO

Ester Baiget, MBA

Website

www.novonesis.com

Headquarters

Lyngby, ND 2800, DK

NVZMF Financials

Key Financial Metrics (TTM)

Gross Margin

54.89%

Operating Margin

21.24%

Net Income Margin

14.70%

Return on Equity

5.79%

Return on Capital

6.37%

Return on Assets

3.80%

Earnings Yield

2.43%

Dividend Yield

1.58%

Payout Ratio

64.22%

Stock Overview

Market Cap

$30.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

466.25M

Volume

584

Avg. Volume

567.313

Financials (TTM)

Gross Profit

€2.35B

Operating Income

€900.38M

EBITDA

€1.44B

Operating Cash Flow

€1.32B

Capital Expenditure

-€512.88M

Free Cash Flow

€803.22M

Cash & ST Invst.

€312.34M

Total Debt

€3.06B

Novozymes A/s Performance Analysis

Novozymes A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 2,479,729,1234.4%
20232023-12-31EUR 2,597,085,2684.7%
20242024-12-31EUR 4,146,661,51459.7%
20252025-12-31EUR 4,692,175,68713.2%
Novozymes A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-304.3%
Q42025-12-31-6.2%
Q12026-03-3112.4%
Q22026-06-30-0.8%
Novozymes A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.864.4%
20232023-12-31EUR 1.58-15.2%
20242024-12-31EUR 0.72-54.4%
20252025-12-31EUR 1.4195.7%
Novozymes A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303.4%
Q42025-12-31-13.3%
Q12026-03-3165.4%
Q22026-06-30-14.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.11B

+9.1%

Gross Profit

€619.07M

+13.7%

Gross Margin

55.70%

N/A

Market Cap

$30.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.60M

N/A

Employees

11,641

N/A

Net Income

€170.97M

+25.0%

EBITDA

€413.05M

+15.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€312.34M

-14.5%

Total Debt

€3.06B

-8.0%

Accounts Receivable

€927.56M

+7.9%

Inventory

€832.94M

+4.2%

Long Term Debt

€2.82B

-5.2%

Short Term Debt

€236.35M

-31.9%

Return on Assets

3.80%

N/A

Return on Invested Capital

5.91%

N/A

Free Cash Flow

€256.58M

+7.9%

Operating Cash Flow

€354.66M

+10.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AKZOYAkzo Nobel N.V.
$21.73+1.40%
SXYAYSika AG
$22.20+0.63%
GVDBFGivaudan S.A.
$3,869.00+0.00%
PPGPPG Industries, Inc.
$107.52+1.13%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.54+3.55%
INTCIntel
$123.00-3.45%
NVDANvidia
$225.07+0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.94-3.02%

Questions About NVZMF

What is the current price of Novozymes A/s?

Novozymes A/s is trading at $65.00 per share.

What is the 52-week range for Novozymes A/s?

Over the past 52 weeks, Novozymes A/s has traded between $52.10 and $72.98.

How much debt does Novozymes A/s have?

As of the most recent reporting period, Novozymes A/s reported total debt of €3.51B.

How much cash does Novozymes A/s have on hand?

Novozymes A/s reported €352.94M in cash and cash equivalents in its most recent financial results.

What is Novozymes A/s’s dividend yield?

Novozymes A/s currently has a dividend yield of 1.58%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services